Basilea Pharmaceutica AG Share Price
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
09:01:47 13/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 53.00 CHF | +0.76% |
|
+3.11% | -3.11% |
| 05/08 | Swiss Market Index Extends Rally; Sandoz Shares Gain | MT |
| 05/08 | Basilea Pharmaceutica Bags Additional $5 Million Funding for Antibiotic Development | MT |
| Market Cap | 66Cr 81Cr 70Cr 60Cr 112.71Cr 7.72TCr 114.52Cr 773.57Cr 302Cr 3.86TCr 303.55Cr 296.97Cr 13TCr | P/E 2026 * |
14.1x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 51Cr 62Cr 54Cr 46Cr 87Cr 5.95TCr 88Cr 596.87Cr 233.02Cr 2.98TCr 234.21Cr 229.14Cr 9.94TCr | EV / Sales 2026 * |
1.93x | EV / Sales 2027 * | 1.65x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | +0.76% | ||
| 1 week | +3.11% | ||
| Current month | +2.12% | ||
| 1 month | -0.19% | ||
| 3 months | -3.99% | ||
| 6 months | -7.02% | ||
| Current year | -3.11% |
| 1 week | 51.8 |  | 53.4 |
| 1 month | 50.4 | | 53.4 |
| Current year | 47.8 | | 59.2 |
| 1 year | 44.7 | | 59.2 |
| 3 years | 32 | | 59.7 |
| 5 years | 29.55 | | 59.7 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/05/26 | Sell | -400 | 0.0030% | |||
| 25/02/26 | Fiscal year | 1,500 | 0.0113% | |||
| 20/02/26 | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | +3.11% | +0.57% | +25.74% | 81Cr | |
| +1.17% | +1.09% | +4.03% | +15.74% | 4.92TCr | |
| -1.59% | +2.12% | +460.02% | +573.56% | 4.33TCr | |
| -0.85% | +7.95% | +15.77% | +80.09% | 4.05TCr | |
| -0.08% | +3.91% | +26.96% | +9.86% | 3.98TCr | |
| 0.00% | +3.59% | +20.51% | +48.00% | 3.27TCr | |
| -3.61% | -1.45% | - | - | 1.62TCr | |
| -2.52% | -0.52% | +24.35% | +118.05% | 1.62TCr | |
| +0.72% | +0.31% | +4.94% | +21.70% | 1.4TCr | |
| -1.09% | +5.94% | +81.46% | +31.15% | 1.34TCr | |
| Average | -0.71% | +2.38% | +70.96% | +102.65% | 2.66TCr | |
| Weighted average by Cap. | -0.57% | +2.71% | +96.24% | +133.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26Cr 32Cr 28Cr 24Cr 45Cr 3.09TCr 46Cr 309.57Cr 120.86Cr 1.55TCr 121.47Cr 118.84Cr 5.16TCr | 27Cr 33Cr 29Cr 24Cr 46Cr 3.14TCr 47Cr 314.94Cr 122.95Cr 1.57TCr 123.58Cr 120.9Cr 5.25TCr |
| Net income | 5.16Cr 6.35Cr 5.5Cr 4.7Cr 8.85Cr 605.7Cr 8.99Cr 61Cr 24Cr 303.2Cr 24Cr 23Cr 1.01TCr | 3.92Cr 4.83Cr 4.19Cr 3.58Cr 6.73Cr 460.9Cr 6.84Cr 46Cr 18Cr 230.71Cr 18Cr 18Cr 769.63Cr |
| Net Debt | -15Cr -18Cr -16Cr -14Cr -26Cr -1.76TCr -26Cr -176.7Cr -69Cr -882.32Cr -69Cr -68Cr -2.94TCr | -21Cr -26Cr -23Cr -20Cr -37Cr -2.52TCr -37Cr -252.98Cr -99Cr -1.26TCr -99Cr -97Cr -4.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | CHF 53.00 | +0.76% | 18,048 |
| 12/26/12 | CHF 52.60 | +1.15% | 44,686 |
| 11/26/11 | CHF 52.00 | -0.19% | 31,420 |
| 10/26/10 | CHF 52.10 | +0.58% | 11,367 |
| 07/26/07 | CHF 51.80 | +0.78% | 19,271 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
